PMCB

PharmaCyte Biotech Inc

3.16
0.05 (1.61%)
Company Name Stock Ticker Symbol Market Type
PharmaCyte Biotech Inc PMCB NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
0.05 1.61% 3.16 20:00:00
Open Price Low Price High Price Close Price Prev Close
3.12 3.10 3.15 3.15 3.11
more quote information »

Recent News

Date Time Source Heading
5/25/202317:14EDGARProxy Statement - Notice of Shareholders Meeting..
5/19/202317:20EDGARStatement of Ownership (sc 13g)
5/12/202316:23EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
5/11/202308:30BWPharmaCyte Biotech Announces Cash Tender Offer for up to..
3/16/202316:43EDGARQuarterly Report (10-q)
2/14/202316:52EDGARAmended Statement of Ownership (sc 13g/a)
2/02/202309:16EDGARCurrent Report Filing (8-k)
2/02/202309:00BWPharmaCyte Biotech to Implement Second $10-Million Share..
1/10/202311:58EDGARAmended Statement of Ownership (sc 13g/a)
12/30/202216:06EDGARInitial Statement of Beneficial Ownership (3)
12/30/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
12/30/202216:06EDGARStatement of Changes in Beneficial Ownership (4)
12/30/202216:06EDGARCurrent Report Filing (8-k)
12/14/202217:22EDGARQuarterly Report (10-q)
11/25/202208:09EDGARProxy Statement (definitive) (def 14a)
11/18/202216:02EDGARCurrent Report Filing (8-k)
11/16/202216:12EDGARInitial Statement of Beneficial Ownership (3)
11/15/202216:44EDGARProxy Statement - Notice of Shareholders Meeting..
10/20/202210:39EDGARStatement of Ownership (sc 13g)
10/14/202216:14EDGARCurrent Report Filing (8-k)
10/11/202204:45TRMNH.C. Wainwright Keeps Their Hold Rating on PharmaCyte..
10/07/202216:54EDGARCurrent Report Filing (8-k)
10/07/202209:00GLOBEPharmaCyte Biotech Board of Directors Announces Business..
8/24/202208:20EDGARInitial Statement of Beneficial Ownership (3)
8/23/202217:51EDGARInitial Statement of Beneficial Ownership (3)
8/23/202206:03EDGARInitial Statement of Beneficial Ownership (3)
8/16/202206:05EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
8/15/202217:39EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
8/15/202208:30BWPharmaCyte Biotech Reaches Cooperation Agreement with..
7/29/202209:42TRMNPharmaCyte Biotech (PMCB) Receives a Hold from H.C...
7/28/202217:17EDGARCurrent Report Filing (8-k)
7/28/202212:49BWPharmaCyte Biotech Rebukes Iroquois’ Commencement of Consent..
7/28/202209:00PRNUSIroquois Files Preliminary Consent Materials to Reconstitute..
7/21/202214:58EDGARCurrent Report Filing (8-k)
7/21/202212:07TRMNPharmaCyte Biotech (PMCB) Gets a Hold Rating from H.C...
7/21/202208:30BWPharmaCyte Biotech Commences First Phase of Two-Phase Pig..
7/19/202217:18EDGARCurrent Report Filing (8-k)
7/19/202217:16EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/19/202208:30BWPharmaCyte Biotech Reports Positive Interim Results in..
7/12/202209:25TRMNAnalysts Have Conflicting Sentiments on These Healthcare..
7/11/202217:23EDGARAdditional Proxy Soliciting Materials - Non-management..
7/11/202216:19EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
7/11/202208:30BWPharmaCyte Biotech Announces Preliminary Unaudited Financial..
7/11/202206:00PRNUSIROQUOIS CAPITAL COMMENCES CONSENT SOLICITATION TO..
7/08/202211:35TRMNH.C. Wainwright Maintains Their Hold Rating on PharmaCyte..
7/05/202215:16PRNUSIROQUOIS CAPITAL ISSUES STATEMENT IN RESPONSE TO RECENT..
7/05/202208:30BWPharmaCyte Biotech Announces Additional Quality Control..
6/23/202216:13EDGARAdditional Proxy Soliciting Materials - Non-management..
6/23/202215:42EDGARAmended Statement of Beneficial Ownership (sc 13d/a)
6/23/202209:00PRNUSIROQUOIS CAPITAL NOMINATES SLATE OF HIGHLY QUALIFIED..